“…Epilepsy (ADNFLE) and Ohtahara syndrome (Heron et al, 2012;Martin et al, 2014). To date, around 60 patients associating KCNT1 mutations and EIMFS are reported with variable and often incomplete information on seizures, EEGs, therapies, MRI and neurodevelopmental status (McTague et al, 2018;Ishii et al, 2013;McTague et al, 2013;Bearden et al, 2014, Mikati et al, 2015bMøller et al, 2015;Ohba et al, 2015;Mori et al, 2016;Rizzo et al, 2016;de Kovel et al, 2016;Baumer and Sheehan, 2017;Zhang et al, 2017;Jee N et al, 2017;Kawasaki et al, 2017;Madaan et al, 2017;Abdelnour et al, 2018;Numis et al, 2018;Dilena et al, 2018). Many questions remain unanswered, mainly on the prognosis and the long-term outcome.…”